A growing battlefield in the war against biofilm-induced antimicrobial resistance: insights from reviews on antibiotic resistance
- PMID: 38188636
- PMCID: PMC10770264
- DOI: 10.3389/fcimb.2023.1327069
A growing battlefield in the war against biofilm-induced antimicrobial resistance: insights from reviews on antibiotic resistance
Abstract
Biofilms are a common survival strategy employed by bacteria in healthcare settings, which enhances their resistance to antimicrobial and biocidal agents making infections difficult to treat. Mechanisms of biofilm-induced antimicrobial resistance involve reduced penetration of antimicrobial agents, increased expression of efflux pumps, altered microbial physiology, and genetic changes in the bacterial population. Factors contributing to the formation of biofilms include nutrient availability, temperature, pH, surface properties, and microbial interactions. Biofilm-associated infections can have serious consequences for patient outcomes, and standard antimicrobial therapies are often ineffective against biofilm-associated bacteria, making diagnosis and treatment challenging. Novel strategies, including antibiotics combination therapies (such as daptomycin and vancomycin, colistin and azithromycin), biofilm-_targeted agents (such as small molecules (LP3134, LP3145, LP4010, LP1062) _target c-di-GMP), and immunomodulatory therapies (such as the anti-PcrV IgY antibodies which _target Type IIIsecretion system), are being developed to combat biofilm-induced antimicrobial resistance. A multifaceted approach to diagnosis, treatment, and prevention is necessary to address this emerging problem in healthcare settings.
Keywords: antimicrobial resistance; biofilms; diagnosis; infections; treatment.
Copyright © 2023 Pai, Patil, Liu and Wen.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Innate and induced resistance mechanisms of bacterial biofilms.Curr Top Microbiol Immunol. 2008;322:85-105. doi: 10.1007/978-3-540-75418-3_5. Curr Top Microbiol Immunol. 2008. PMID: 18453273 Review.
-
Bacterial biofilm infections, their resistance to antibiotics therapy and current treatment strategies.Biomed Mater. 2022 Feb 14;17(2). doi: 10.1088/1748-605X/ac50f6. Biomed Mater. 2022. PMID: 35105823 Review.
-
Impact of CRAMP-34 on Pseudomonas aeruginosa biofilms and extracellular metabolites.Front Cell Infect Microbiol. 2023 Dec 13;13:1295311. doi: 10.3389/fcimb.2023.1295311. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 38162583 Free PMC article.
-
Biofilms in vitro and in vivo: do singular mechanisms imply cross-resistance?J Appl Microbiol. 2002;92 Suppl:98S-110S. J Appl Microbiol. 2002. PMID: 12000619 Review.
-
Optimization of Phage-Antibiotic Combinations against Staphylococcus aureus Biofilms.Microbiol Spectr. 2023 Jun 15;11(3):e0491822. doi: 10.1128/spectrum.04918-22. Epub 2023 May 18. Microbiol Spectr. 2023. PMID: 37199616 Free PMC article.
Cited by
-
What is the role of microbial biotechnology and genetic engineering in medicine?Microbiologyopen. 2024 Apr;13(2):e1406. doi: 10.1002/mbo3.1406. Microbiologyopen. 2024. PMID: 38556942 Free PMC article. Review.
-
Sonodynamic effect based on vancomycin-loaded microbubbles or meropenem-loaded microbubbles enhances elimination of different biofilms and bactericidal efficacy.Bone Joint Res. 2024 Sep 3;13(9):441-451. doi: 10.1302/2046-3758.139.BJR-2023-0319.R3. Bone Joint Res. 2024. PMID: 39222931 Free PMC article.
-
What Is a Biofilm? Lessons Learned from Interactions with Immune Cells.Int J Mol Sci. 2024 Oct 30;25(21):11684. doi: 10.3390/ijms252111684. Int J Mol Sci. 2024. PMID: 39519236 Free PMC article. Review.
-
Three New Ent-Kaurane Diterpenes with Antibacterial Activity from Sigesbeckia orientalis.Molecules. 2024 Sep 29;29(19):4631. doi: 10.3390/molecules29194631. Molecules. 2024. PMID: 39407562 Free PMC article.
-
Editorial: The ever so elusive pathogen-harboring biofilms on abiotic surfaces in the food and clinical sectors: the good, the bad and the slimy.Front Cell Infect Microbiol. 2024 Feb 9;14:1374693. doi: 10.3389/fcimb.2024.1374693. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38404285 Free PMC article. No abstract available.
References
-
- Alshammari M., Ahmad A., AlKhulaifi M., Al Farraj D., Alsudir S., Alarawi M., et al. . (2023). Reduction of biofilm formation of Escherichia coli by _targeting quorum sensing and adhesion genes using the CRISPR/Cas9-HDR approach, and its clinical application on urinary catheter. J. Infect. Public Health 16, 1174–1183. doi: 10.1016/j.jiph.2023.05.026 - DOI - PubMed
-
- Andersen J. B., Hultqvist L. D., Jansen C. U., Jakobsen T. H., Nilsson M., Rybtke M., et al. . (2021. a). Identification of small molecules that interfere with c-di-GMP signaling and induce dispersal of Pseudomonas aeruginosa biofilms. NPJ Biofilms Microbiomes 7, 59. doi: 10.1038/s41522-021-00225-4 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical